Testing effectiveness (Phase 2)Study completedNCT04930562
What this trial is testing
Efficacy and Safety of BN101 in Subjects With Chronic Graft Versus Host Disease (cGVHD)
Who this might be right for
GVHD, Chronic
BioNova Pharmaceuticals (Shanghai) LTD. 30